Literature DB >> 9753280

Quantitative and ultrastructural analysis of rectal mucosal mast cells in acute infectious diarrhea.

A B Pulimood1, M M Mathan, V I Mathan.   

Abstract

The role of mast cells, potential mediators of mucosal immunity and inflammation, was studied morphologically in the rectal mucosa in two acute diarrheal diseases, cholera and shigellosis. Quantitation of mucosal mast cells showed that they were significantly higher in the deeper lamina propria where blood vessels and nerves were more abundant. There was no difference in mast cell counts or degranulation in the mucosa in both groups of patients and controls. Intraepithelial mast cells were decreased in the patients. The prevalence of lipid bodies was significantly higher in mast cells from patients with cholera and shigellosis (P < 0.01). These findings suggest that mast cell populations are more dense around blood vessels and nerves and that inflammatory mediators derived from arachidonic acid metabolites, as indicated by the lipid bodies, are the response of mast cells to the alterations in diarrhea, despite differences in the etiology of diarrhea.

Entities:  

Mesh:

Year:  1998        PMID: 9753280     DOI: 10.1023/a:1018875718392

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  The presence and distribution of mast cells in the human gastrointestinal tract at autopsy.

Authors:  H T NORRIS; N ZAMCHECK; L S GOTTLIEB
Journal:  Gastroenterology       Date:  1963-04       Impact factor: 22.682

2.  Distribution of mast cells in human ileocecal region.

Authors:  S Bacci; S Faussone-Pellegrini; B Mayer; P Romagnoli
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Bacterial lipopolysaccharide-induced intestinal microvascular lesions leading to acute diarrhea.

Authors:  V I Mathan; G R Penny; M M Mathan; D Rowley
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 4.  Mast cells and paneth cells in ulcerative colitis.

Authors:  S C Sommers
Journal:  Gastroenterology       Date:  1966-11       Impact factor: 22.682

5.  Local Shwartzman reaction in the rectal mucosa in acute diarrhoea.

Authors:  M M Mathan; V I Mathan
Journal:  J Pathol       Date:  1985-07       Impact factor: 7.996

6.  Ultrastructural changes in the upper small intestinal mucosa in patients with cholera.

Authors:  M M Mathan; G Chandy; V I Mathan
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

7.  Rectal mucosal morphologic abnormalities in normal subjects in southern India: a tropical colonopathy?

Authors:  M M Mathan; V I Mathan
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

8.  Crohn's disease--mast cell quantitation using one micron plastic sections for light microscopic study.

Authors:  A M Dvorak; R A Monahan
Journal:  Pathol Annu       Date:  1983

9.  Altered inflammatory reaction in nonspecific ulcerative colitis.

Authors:  Z T Bercovitz; S C Sommers
Journal:  Arch Intern Med       Date:  1966-04

10.  Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo.

Authors:  A M Dvorak; R S McLeod; A Onderdonk; R A Monahan-Earley; J B Cullen; D A Antonioli; E Morgan; J E Blair; P Estrella; R L Cisneros
Journal:  Int Arch Allergy Immunol       Date:  1992       Impact factor: 2.749

View more
  11 in total

1.  Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line.

Authors:  C A King; J S Marshall; H Alshurafa; R Anderson
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea.

Authors:  Chien-Chang Chen; Chee-Jen Chang; Tzou-Yien Lin; Ming-Wei Lai; Hsun-Chin Chao; Man-Shan Kong
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

3.  Persistence of mucosal mast cells and eosinophils in Shigella-infected children.

Authors:  Rubhana Raqib; Pricila Khan Moly; Protim Sarker; Firdausi Qadri; Nurul Haque Alam; Minnie Mathan; Jan Andersson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Innate immune responses in children and adults with Shigellosis.

Authors:  R Raqib; S M Mia; F Qadri; T I Alam; N H Alam; A K Chowdhury; M M Mathan; J Andersson
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139.

Authors:  Firdausi Qadri; Rubhana Raqib; Firoz Ahmed; Taufiqur Rahman; Christine Wenneras; Swadesh Kumar Das; Nur Haque Alam; Minnie M Mathan; Ann-Mari Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 6.  The Complex Link and Disease Between the Gut Microbiome and the Immune System in Infants.

Authors:  Huan Zhang; Zhilin Zhang; Yiqun Liao; Wenjie Zhang; Dong Tang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

7.  Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut.

Authors:  F Qadri; T R Bhuiyan; K K Dutta; R Raqib; M S Alam; N H Alam; A-M Svennerholm; M M Mathan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Development of colorectal sensitization is associated with increased eosinophils and mast cells in dextran sulfate sodium-treated rats.

Authors:  J M Tobin; L M D Delbridge; R Di Nicolantonio; P Bhathal
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 9.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

10.  Antidiarrhoeal activity of the standardised extract of Cinnamomum tamala in experimental rats.

Authors:  Chandana Venkateswara Rao; Madhavan Vijayakumar; K Sairam; Vikas Kumar
Journal:  J Nat Med       Date:  2008-05-21       Impact factor: 2.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.